Page last updated: 2024-10-30

metformin and Cancer of the Thymus

metformin has been researched along with Cancer of the Thymus in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Popovich, IG1
Piskunova, TS1
Tyndyk, ML1
Anikin, IV1
Zabezhinskiĭ, MA1
Anisimov, VN1

Other Studies

1 other study available for metformin and Cancer of the Thymus

ArticleYear
[Metformin effect on urethane-induced tumorigenesis in mice].
    Voprosy onkologii, 2012, Volume: 58, Issue:4

    Topics: Adenoma; Administration, Oral; Animals; Anticarcinogenic Agents; Carcinogens; Cell Transformation, N

2012